Role of connective tissue growth factor and its interaction with basic fibroblast growth factor and macrophage chemoattractant protein-1 in skin fibrosis
- PMID: 19277979
- DOI: 10.1002/jcp.21750
Role of connective tissue growth factor and its interaction with basic fibroblast growth factor and macrophage chemoattractant protein-1 in skin fibrosis
Abstract
Activation of the immune system and abnormal growth of skin fibroblasts cause systemic sclerosis. Growth factors have various biological activities, including mediation of immune reactions. The growth factor family includes basic fibroblast growth factor (bFGF), transforming growth factor-beta (TGF-beta), and connective tissue growth factor (CTGF). CTGF, an important downstream mediator of TGF-beta in fibrosis, has been suggested to play a specific role in fibrotic disorders. We have directed our attention to the role of CTGF in sustaining skin fibrosis. To better understand its effects in vivo, we established an animal model of skin fibrosis induced by exogenous application of growth factors. In this model, bFGF transiently induced subcutaneous fibrosis. Simultaneous injection of bFGF and CTGF increased skin fibrosis compared with a single injection of bFGF. Serial injections of bFGF for 3 days followed by CTGF for 4 days, or of CTGF followed by bFGF, did not cause skin fibrosis but simultaneous injections increased macrophage chemoattractant protein-1 (MCP-1) mRNA expression levels. To further define the mechanisms of skin fibrosis in vivo, bFGF and CTGF were injected simultaneously into MCP-1 knockout mice, resulting in decreased collagen levels in granulation tissues on day 8. The number of inflammatory cells, such as mast cells, macrophages and lymphocytes, was significantly decreased in MCP-1 knockout mice compared with wild-type mice. These results suggest that bFGF induces collagen production by stimulating skin fibroblasts and CTGF cooperates with bFGF. Our results indicate that the induction of MCP-1 is necessary for infiltration of inflammatory cells.
Similar articles
-
Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model.J Cell Physiol. 2005 May;203(2):447-56. doi: 10.1002/jcp.20251. J Cell Physiol. 2005. PMID: 15605379
-
Chemokine receptors CCR2 and CX3CR1 regulate skin fibrosis in the mouse model of cytokine-induced systemic sclerosis.J Dermatol Sci. 2013 Mar;69(3):250-8. doi: 10.1016/j.jdermsci.2012.10.010. Epub 2012 Oct 24. J Dermatol Sci. 2013. PMID: 23142052
-
Role and interaction of connective tissue growth factor with transforming growth factor-beta in persistent fibrosis: A mouse fibrosis model.J Cell Physiol. 1999 Oct;181(1):153-9. doi: 10.1002/(SICI)1097-4652(199910)181:1<153::AID-JCP16>3.0.CO;2-K. J Cell Physiol. 1999. PMID: 10457363
-
Transcriptional profiling of the scleroderma fibroblast reveals a potential role for connective tissue growth factor (CTGF) in pathological fibrosis.Keio J Med. 2004 Jun;53(2):74-7. doi: 10.2302/kjm.53.74. Keio J Med. 2004. PMID: 15247510 Review.
-
Growth regulation of skin fibroblasts.J Dermatol Sci. 2000 Dec;24 Suppl 1:S70-7. doi: 10.1016/s0923-1811(00)00144-4. J Dermatol Sci. 2000. PMID: 11137399 Review.
Cited by
-
Distinct macrophage populations and phenotypes associated with IL-4 mediated immunomodulation at the host implant interface.Biomater Sci. 2020 Oct 21;8(20):5751-5762. doi: 10.1039/d0bm00568a. Epub 2020 Sep 18. Biomater Sci. 2020. PMID: 32945303 Free PMC article.
-
Molecular Mechanism of Traditional Chinese Ointment of Xuzhou Qufu Shengji in Infected Wounds.Evid Based Complement Alternat Med. 2022 Jan 12;2022:4116563. doi: 10.1155/2022/4116563. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 35069758 Free PMC article.
-
Expression of connective tissue growth factor in the livers of non-viral hepatocellular carcinoma patients with metabolic risk factors.J Gastroenterol. 2016 Sep;51(9):910-22. doi: 10.1007/s00535-015-1159-8. Epub 2016 Jan 6. J Gastroenterol. 2016. PMID: 26739296
-
Natural antioxidants attenuate mycolactone toxicity to RAW 264.7 macrophages.Exp Biol Med (Maywood). 2021 Sep;246(17):1884-1894. doi: 10.1177/15353702211015628. Epub 2021 May 26. Exp Biol Med (Maywood). 2021. PMID: 34038223 Free PMC article.
-
Clinical, cellular, and molecular aspects in the pathophysiology of rosacea.J Investig Dermatol Symp Proc. 2011 Dec;15(1):2-11. doi: 10.1038/jidsymp.2011.7. J Investig Dermatol Symp Proc. 2011. PMID: 22076321 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous